Xilong Scientific Co Ltd
SZSE:002584
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xilong Scientific Co Ltd
SZSE:002584
|
CN |
Balance Sheet
Balance Sheet Decomposition
Xilong Scientific Co Ltd
Xilong Scientific Co Ltd
Balance Sheet
Xilong Scientific Co Ltd
| Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
104
|
138
|
123
|
420
|
458
|
488
|
264
|
821
|
439
|
255
|
684
|
923
|
492
|
770
|
330
|
151
|
179
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
329
|
151
|
179
|
|
| Cash Equivalents |
104
|
138
|
123
|
420
|
457
|
486
|
263
|
820
|
438
|
254
|
683
|
923
|
492
|
770
|
1
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
153
|
61
|
349
|
0
|
0
|
|
| Total Receivables |
119
|
155
|
159
|
217
|
269
|
291
|
351
|
397
|
480
|
505
|
963
|
711
|
1 317
|
1 722
|
1 742
|
1 775
|
1 802
|
|
| Accounts Receivables |
105
|
120
|
135
|
189
|
210
|
243
|
297
|
329
|
402
|
376
|
704
|
596
|
1 178
|
992
|
1 291
|
1 601
|
1 644
|
|
| Other Receivables |
14
|
35
|
23
|
28
|
60
|
49
|
53
|
68
|
78
|
129
|
259
|
115
|
139
|
730
|
452
|
174
|
158
|
|
| Inventory |
95
|
133
|
141
|
198
|
267
|
238
|
265
|
324
|
326
|
324
|
349
|
395
|
713
|
454
|
508
|
562
|
620
|
|
| Other Current Assets |
25
|
19
|
24
|
28
|
37
|
100
|
47
|
50
|
127
|
499
|
269
|
875
|
619
|
691
|
758
|
842
|
686
|
|
| Total Current Assets |
343
|
445
|
447
|
863
|
1 031
|
1 117
|
926
|
1 593
|
1 371
|
1 583
|
2 265
|
2 904
|
3 295
|
3 699
|
3 688
|
3 329
|
3 288
|
|
| PP&E Net |
81
|
105
|
159
|
203
|
285
|
386
|
485
|
551
|
590
|
594
|
592
|
566
|
520
|
491
|
725
|
867
|
838
|
|
| PP&E Gross |
0
|
105
|
159
|
203
|
285
|
386
|
485
|
551
|
590
|
594
|
592
|
566
|
520
|
491
|
725
|
867
|
838
|
|
| Accumulated Depreciation |
0
|
19
|
24
|
31
|
43
|
59
|
92
|
111
|
132
|
159
|
183
|
203
|
178
|
172
|
205
|
238
|
261
|
|
| Intangible Assets |
39
|
64
|
63
|
64
|
73
|
70
|
75
|
75
|
77
|
81
|
91
|
80
|
65
|
63
|
148
|
179
|
180
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
69
|
66
|
66
|
66
|
404
|
387
|
375
|
375
|
7
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
3
|
3
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
99
|
97
|
254
|
145
|
134
|
275
|
146
|
157
|
373
|
370
|
362
|
|
| Other Long-Term Assets |
2
|
2
|
2
|
4
|
5
|
5
|
8
|
9
|
15
|
14
|
23
|
19
|
21
|
26
|
21
|
21
|
45
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
69
|
66
|
66
|
66
|
404
|
387
|
375
|
375
|
7
|
0
|
0
|
|
| Total Assets |
465
N/A
|
615
+32%
|
670
+9%
|
1 134
+69%
|
1 394
+23%
|
1 578
+13%
|
1 661
+5%
|
2 391
+44%
|
2 373
-1%
|
2 483
+5%
|
3 509
+41%
|
4 231
+21%
|
4 422
+5%
|
4 810
+9%
|
4 977
+3%
|
4 769
-4%
|
4 716
-1%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
56
|
78
|
71
|
74
|
78
|
102
|
103
|
147
|
167
|
148
|
241
|
426
|
411
|
537
|
1 178
|
950
|
988
|
|
| Accrued Liabilities |
3
|
3
|
5
|
4
|
5
|
13
|
13
|
19
|
16
|
31
|
42
|
78
|
48
|
52
|
57
|
48
|
47
|
|
| Short-Term Debt |
52
|
135
|
134
|
25
|
194
|
386
|
278
|
304
|
241
|
436
|
970
|
1 402
|
1 497
|
1 515
|
917
|
833
|
725
|
|
| Current Portion of Long-Term Debt |
32
|
24
|
28
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
47
|
31
|
0
|
121
|
68
|
165
|
130
|
|
| Other Current Liabilities |
34
|
31
|
29
|
23
|
65
|
36
|
109
|
107
|
102
|
89
|
112
|
40
|
196
|
167
|
122
|
73
|
98
|
|
| Total Current Liabilities |
177
|
272
|
267
|
127
|
342
|
537
|
503
|
577
|
526
|
703
|
1 412
|
1 976
|
2 152
|
2 392
|
2 342
|
2 070
|
1 988
|
|
| Long-Term Debt |
16
|
20
|
17
|
0
|
0
|
0
|
7
|
7
|
27
|
47
|
270
|
217
|
175
|
109
|
299
|
325
|
379
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
2
|
0
|
6
|
7
|
3
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
2
|
0
|
32
|
75
|
69
|
25
|
57
|
57
|
72
|
81
|
6
|
6
|
6
|
|
| Other Liabilities |
6
|
7
|
7
|
5
|
10
|
11
|
13
|
10
|
9
|
10
|
7
|
35
|
4
|
3
|
14
|
13
|
41
|
|
| Total Liabilities |
200
N/A
|
299
+50%
|
291
-3%
|
132
-55%
|
354
+169%
|
548
+55%
|
555
+1%
|
669
+21%
|
631
-6%
|
786
+24%
|
1 749
+123%
|
2 289
+31%
|
2 405
+5%
|
2 585
+7%
|
2 667
+3%
|
2 421
-9%
|
2 416
0%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
150
|
150
|
150
|
200
|
200
|
200
|
200
|
234
|
585
|
585
|
585
|
585
|
585
|
585
|
585
|
585
|
585
|
|
| Retained Earnings |
53
|
104
|
167
|
219
|
256
|
248
|
324
|
412
|
490
|
554
|
629
|
672
|
762
|
958
|
1 042
|
1 080
|
1 032
|
|
| Additional Paid In Capital |
62
|
62
|
62
|
584
|
584
|
582
|
582
|
1 076
|
678
|
677
|
677
|
677
|
669
|
682
|
682
|
682
|
682
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
118
|
131
|
8
|
0
|
0
|
1
|
1
|
1
|
|
| Total Equity |
265
N/A
|
316
+19%
|
379
+20%
|
1 003
+165%
|
1 040
+4%
|
1 030
-1%
|
1 106
+7%
|
1 722
+56%
|
1 741
+1%
|
1 697
-3%
|
1 760
+4%
|
1 942
+10%
|
2 017
+4%
|
2 226
+10%
|
2 311
+4%
|
2 348
+2%
|
2 300
-2%
|
|
| Total Liabilities & Equity |
465
N/A
|
615
+32%
|
670
+9%
|
1 134
+69%
|
1 394
+23%
|
1 578
+13%
|
1 661
+5%
|
2 391
+44%
|
2 373
-1%
|
2 483
+5%
|
3 509
+41%
|
4 231
+21%
|
4 422
+5%
|
4 810
+9%
|
4 977
+3%
|
4 769
-4%
|
4 716
-1%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
500
|
500
|
375
|
500
|
500
|
500
|
500
|
585
|
585
|
585
|
585
|
585
|
585
|
585
|
585
|
585
|
585
|
|